XAEONX.AI WORLD'S FIRST AI PSYCHIATRIC PREDICTION SYSTEM DR. JODY REED, MD • 26 YEARS • CHICAGO FREE TO EVERY PATIENT • ANY SETTING • ANY DEVICE • ALWAYS SERIES A: $15M • Q3 2026 TELEHEALTH • OUTPATIENT • INPATIENT • EMERGENCY ROOM • SCHOOLS • JAILS • PRISONS • COMMUNITY MH REFERRAL NETWORK: REAL-TIME PATIENT TRANSITIONS IN <4 MINUTES ANY PROVIDER • ANY FACILITY • ANY INSTITUTION • SIGN UP TODAY YR 5 REVENUE: $106M THE MAN WITHOUT AI FIGHTS WITH HIS FISTS IN THE FUTURE ● XAEONX.AI STORE: MERCH • CLINICAL TOOLS • WELLNESS • DIGITAL DOWNLOADS ● XAEONX.AI MEDIA: DR. REED VIDEOS • CLINICAL EDUCATION • PATIENT STORIES XAEONX.AI WORLD'S FIRST AI PSYCHIATRIC PREDICTION SYSTEM DR. JODY REED, MD • 26 YEARS • CHICAGO FREE TO EVERY PATIENT • ANY SETTING • ANY DEVICE • ALWAYS SERIES A: $15M • Q3 2026 TELEHEALTH • OUTPATIENT • INPATIENT • EMERGENCY ROOM • SCHOOLS • JAILS • PRISONS • COMMUNITY MH REFERRAL NETWORK: REAL-TIME PATIENT TRANSITIONS IN <4 MINUTES ANY PROVIDER • ANY FACILITY • ANY INSTITUTION • SIGN UP TODAY
THREE CAPABILITIES  //  ONE PLATFORM  //  NEVER EXISTED BEFORE
Patient-Owned EMR
AI Prediction System
Continuous RWE Platform

THE FIRST
ON-DEMAND
MENTAL HEALTH
WALK-IN CLINIC.

xaeonx.ai is three capabilities simultaneously — and the combination has never existed before in any healthcare platform. Patient-owned distributed EMR (free to patients, developed inside xaeonx.ai). AI psychiatric prediction (6 years deployed, 100,000+ inpatient visits, zero inter-rater variability). Continuous Real-World Evidence Platform (FDA Learning Health System model). On-demand walk-in clinic — provider available immediately after assessment. Crisis line with direct ER referral. Direct admit operational.

100K+
Inpatient visits
deployed
6 yrs
Operational
history
$106M
Year 5 platform
revenue
FREE
EMR + assessment
to every patient
// global_patient_reach_projection
970M+
Global untreated mental health patients addressable by xaeonx.ai
Year 1 Patients Assessed48K
Year 3 Patients Assessed640K
Year 5 Patients Assessed4.2M
Care Settings in Network12 settings • 50+ states
$106M
Year 5 annual
platform revenue
12
Care settings
supported
<4 min
Avg referral
match time
26 yrs
Dr. Reed single-rater
clinical database
FREE
Assessment for
every patient always
Every Care Setting

xaeonx.ai goes
wherever patients are.

Any healthcare provider, facility, or institution can sign up to xaeonx.ai and immediately offer a full range of AI-powered mental health assessments — white-labeled under their own brand. From a solo telehealth provider to a statewide corrections system, xaeonx.ai deploys in hours and connects to the referral network on day one.

💻
● LIVE NOW
Online / Telehealth
Deploy as your virtual front door. Patients complete a full psychiatric prediction assessment before their visit — clinicians receive structured intake data before the first word is spoken. Works with any video platform.
34 min
Avg intake
time saved
100%
Remote
deployment
🏠
● LIVE NOW
Outpatient Clinics
Replace paper intake forms entirely. Patients complete their assessment before arrival. Clinicians receive prediction profiles at appointment start. Track treatment progress session over session against Dr. Reed’s 26-year outcomes database.
34 min
Saved per
intake
94%
Prediction
accuracy
🏥
● LIVE NOW
Inpatient Units
Continuous monitoring assessments throughout a psychiatric admission. Track patient progress in real time. Automated discharge readiness indicators. Post-discharge referral recommendations routed directly through the network.
Daily
Monitoring
cadence
Auto
Discharge
readiness
🚨
⚡ CRITICAL IMPACT
Emergency Room
Immediate psychiatric triage for every ED patient presenting with behavioral health concerns. Eliminates the average 11-hour wait. Generates a risk stratification profile in minutes. Identifies boarding-diversion candidates automatically. Saves $2,264 per diverted episode.
11 hrs
ER wait
bypassed
$2,264
Saved per
diversion
🏫
● EDUCATION MODULE
Schools & Universities
Early identification of students at risk for psychiatric crisis. Age-appropriate assessment modules for K–12 and higher education. FERPA-compliant. Counselors use xaeonx.ai as their first-touch screening tool before escalating to licensed clinicians.
K–12
Age-adapted
modules
FERPA
Compliant
always
🔒
● CORRECTIONS MODULE
Jails & Pre-Trial Detention
Psychiatric screening at booking. Identifies individuals in acute crisis before general population placement. Reduces in-custody psychiatric emergencies. Flags high-risk individuals within hours of arrival for immediate clinical intervention — before a crisis becomes a catastrophe.
At booking
Immediate
screening
20%+
Jail population
w/ SMI
🌎
● CORRECTIONS MODULE
Prisons & Corrections
Ongoing psychiatric monitoring for incarcerated individuals. Longitudinal assessment tracking over months and years. Reentry mental health planning powered by Dr. Reed’s outcomes data. Connects directly to community mental health on release day — no gap in care.
2.3M
Incarcerated
in the US
Reentry
Care continuity
on release
🏚
● FQHC READY
Community Mental Health
FQHCs, CMHCs, and community health centers deploy xaeonx.ai as their primary psychiatric assessment tool — no on-site psychiatrist required. The AI handles triage, assessment, and referral routing. Reduces waitlists by pre-stratifying patients by acuity level.
0
Psychiatrists
required
FQHC
Billing
compatible
🩺
● Colony CampusTED CARE
Primary Care & FQHCs
Behavioral health integration at the point of primary care. Any PCP, family medicine, or internal medicine practice screens every patient for psychiatric conditions — without a specialist referral. Identifies undiagnosed mental illness during routine care visits.
1 in 5
PCP visits
involve MH
Same-day
Screening
results
👴
● DUAL DIAGNOSIS
Substance Use Programs
Dual diagnosis assessment at intake for every SUD patient. Co-occurring psychiatric disorders identified before treatment starts — not weeks later when progress stalls. Dr. Reed’s database includes extensive dual-diagnosis outcomes data from 26 years of real-world practice.
50%+
SUD patients
have co-occurring
At intake
Dual-diagnosis
screening
🚶
● HIGH IMPACT
Homeless & Shelter Services
Psychiatric assessment for individuals experiencing homelessness — one of the highest-acuity, most underserved populations in America. No insurance. No appointment. No barrier. Generates immediate referrals to mental health services, housing programs, and crisis support.
30%+
Homeless w/
serious MH
$0
Cost to
patient
💊
● UNIVERSAL
Any Provider or Institution
VA facilities. Pediatric clinics. Senior care. Refugee resettlement. Corporate wellness. Tribal health. If you interact with people who need mental health support — xaeonx.ai can be deployed in your setting within hours, white-labeled under your brand, connected to the referral network.
Hours
Time to
deployment
Any
Setting
supported
// care_setting_er_burden
Psychiatric ER Burden — Before vs After xaeonx.ai
Average hours per psychiatric ER visit vs xaeonx.ai pathway
xaeonx.ai bypasses the ER pathway entirely for appropriate cases • $2,264 saved per patient
// unmet_need_by_setting
Unmet Psychiatric Need by Care Setting (millions of people)
People in each setting who need but cannot access psychiatric care
xaeonx.ai addresses all 12 settings simultaneously • No other platform can make this claim
The xaeonx.ai Referral Network

Right patient.
Right destination.
Under 4 minutes.

When any patient completes a xaeonx.ai assessment — in any setting, anywhere in the world — the platform immediately matches them to the most appropriate next level of care from the xaeonx.ai Referral Network. Every registered provider becomes a node. Transition delays are eliminated. The right patient reaches the right destination faster than any human referral process can achieve.

🧑
01
Patient Completes Assessment
Any setting. Any device. Any language. Online, in a waiting room, an ER triage bay, a school nurse office, or at jail booking. The assessment takes 8–12 minutes. It is always free.
Any of 12 care settings
🧠
02
AI Generates Prediction Profile
xaeonx.ai analyzes responses against Dr. Reed’s 26-year database and assigns a risk stratification level — Crisis, Acute, Moderate, Mild, or Preventive — with a full clinical prediction profile.
Real-time • <60 seconds
🌐
03
Network Match Generated
The AI queries the live referral network for the nearest, most appropriate available provider. Filters by specialty, acuity level, insurance, language, setting type, and current capacity.
Average match: <4 minutes
🎯
04
Warm Handoff Initiated
The receiving provider gets the patient’s full xaeonx.ai prediction profile before the patient arrives. No cold handoffs. No starting from zero. No lost clinical information. The transition is seamless.
Full profile transferred
12
Care settings
in the network
50+
States &
territories
<4 min
Average
match time
24/7
Always
active
5
Risk tiers
stratified
$0
Patient
cost always
Risk Stratification Tiers

Every patient routed to
exactly the right level.

xaeonx.ai assigns every patient to one of five risk tiers. Each tier has a defined referral pathway, a target time to care, and a set of eligible receiving providers in the network. No patient falls through the cracks.

CRISIS
Tier 1
Immediate risk to self or others. Active suicidality, psychosis, or acute danger. Referral to emergency psychiatric services or 911 initiated within 60 seconds.
⭐ Response: <60 sec
➔ ED • Crisis Center • Mobile Crisis
ACUTE
Tier 2
Significant psychiatric symptoms requiring prompt evaluation. Inpatient admission or PHP level of care indicated. Referral generated and sent within 4 minutes.
⭐ Response: <4 min
➔ Inpatient • PHP • Crisis Stabilization
MODERATE
Tier 3
Moderate psychiatric symptoms requiring scheduled clinical evaluation. IOP or outpatient referral within 48 hours. Patient receives appointment confirmation immediately.
⭐ Response: <48 hrs
➔ IOP • Outpatient • Telehealth
MILD
Tier 4
Mild symptoms. Outpatient therapy or primary care behavioral health integration recommended. Self-scheduling link and provider options delivered to patient directly.
⭐ Response: Self-schedule
➔ Outpatient • Primary Care • Peer Support
PREVENTIVE
Tier 5
No acute symptoms. Psychoeducation, wellness resources, and optional follow-up screening provided. Patient remains in the network for longitudinal monitoring.
⭐ Response: Educational
➔ Wellness • Peer Support • Re-screening
// referral_time_comparison
Referral Speed: xaeonx.ai vs Traditional
Hours to reach next level of care (lower = better)
Traditional psychiatric referrals take days to weeks • xaeonx.ai: minutes
// network_referral_volume
Network Referral Volume Growth
Monthly referrals processed through xaeonx.ai network, Year 1–5
Every new provider joining the network increases value for all others
// referral_outcomes
Referral Success Rate by Setting
% of xaeonx.ai referrals resulting in completed care transition
Warm handoff + full prediction profile = dramatically higher completion rates
Why Institutions Join

Sign up today.
Live in hours.

Deployed in Hours, Not Months
Sign up. Upload your logo. Your branded xaeonx.ai is live within hours. No IT project. No lengthy implementation. Basic deployment requires zero EHR integration. Enterprise integration available for Epic, Cerner, Athena, eClinicalWorks, and any HL7 / FHIR system.
🌐
Instant Referral Network Access
The moment you register, you join the xaeonx.ai Referral Network. You can receive referrals from every other institution on the platform immediately. No separate application. No waiting period. Every patient your AI assesses can be routed to the right destination in minutes.
📊
Population Health Dashboard
Track assessment volumes, acuity distributions, referral success rates, and outcomes across your entire patient population. Real-time analytics benchmarked against Dr. Reed’s 26-year outcomes data. Know exactly how your population compares and where to direct resources.
Colony DAO Token Earnings
Every verified clinical event your institution generates earns COLONY tokens — a permanent, appreciating data asset. Hospitals, clinics, corrections facilities, and schools can accumulate significant Colony DAO token portfolios that generate staking yield of $7.38–$38.10 per token per year.
👩‍⚕️
No On-Site Psychiatrist Required
xaeonx.ai provides world-class psychiatric assessment intelligence. Your facility does not need a psychiatrist on staff to deploy this capability. Ideal for rural hospitals, primary care clinics, schools, jails, shelters, and any setting where specialist access is limited or absent.
🔒
HIPAA • FERPA • CJIS Compliant
All patient data is AES-256 encrypted and stored under HIPAA-compliant protocols. School deployments meet FERPA requirements. Corrections deployments meet CJIS security standards. Colony DAO constitutional privacy provisions protect all data permanently and irrevocably.
Institutional Pricing

Affordable at every scale.
Free for patients. Always.

Patient assessments are always free. Institutional pricing is based on volume, features, and integration depth. Every tier includes full Referral Network access from day one.

Solo Provider
Individual clinician • Any specialty
$499/mo
Up to 200 assessments / month
Your photo & branded AI name
Full Referral Network access
Consultation request routing
Colony DAO token earnings
Basic analytics dashboard
Email support
Enterprise / System
Unlimited clinicians • System-wide
Custom
Unlimited clinicians & assessments
System-wide white-label deployment
Custom AI training on your data
Private referral network subdomain
Custom EHR / HL7 / FHIR API
Corrections module (jails & prisons)
School system / FERPA module
On-site implementation support
Colony DAO governance seat
SLA • 24/7 technical support
JR
Dr. Jody Reed, MD
Psychiatrist • Founder, 5D Earth • South Side Chicago • 26 Years in Practice
The man without AI will be the man who is forced to fight with his fists in the future. I spent 26 years building a clinical database that no institution on earth can replicate. Now I’ve turned it into an AI that will practice my expertise — free — for every patient on the planet, in every care setting, for a thousand years. xaeonx.ai is not just a tool. It is my legacy. And it belongs to every patient I have ever treated, and every patient I never had the chance to meet.

xaeonx.ai is now available to any healthcare provider, facility, or institution — online, outpatient, inpatient, emergency room, schools, jails, prisons, community mental health, and beyond. Sign up today. Deploy in hours. Your patients deserve this. Every patient deserves this.

Why xaeonx.ai Exists

970 million people.
No access. No care.
One solution.

970 million people have untreated mental health conditions. The system is broken — long waits, high costs, impossible access, and a 17-year gap between evidence and practice. xaeonx.ai is three capabilities simultaneously — patient-owned EMR, AI prediction, and Continuous Real-World Evidence Platform — deployed and operating for six years.

// global_mental_health_burden
Global Mental Health Burden by Region
Estimated untreated people by region (millions)
xaeonx.ai is free in every country • Zero geographic barrier
// treatment_gap_by_income
The Treatment Gap
% of people with mental illness receiving NO treatment by income level
In low-income countries 85%+ receive no treatment • xaeonx.ai costs $0
// er_psychiatric_crisis
The ER Crisis
Average hours lost per psychiatric ER visit vs xaeonx.ai
xaeonx.ai bypasses the ER • $2,264 saved per diverted patient
00
Mandatory Crisis Screening
Before any assessment begins, every patient is asked: “Are you currently having thoughts of suicide or harming yourself?”

If YES → immediate 911 connection or live licensed crisis provider. Assessment stops. Patient is safe first.
If NO → full assessment begins.
EVERY SESSION • TIMESTAMPED • DOCUMENTED
01
📋
Structured Assessment
The patient completes a structured psychiatric and psychosocial history — symptoms, severity, duration, treatment history, functional impairment. Matched against the 100,000+ visit database to identify the historical cohort: people most clinically similar, assessed on identical instruments.
FREE • ALL LANGUAGES • 24/7
02
🧠
AI Cohort Matching & Pathway
xaeonx.ai matches against Dr. Reed’s 100,000+ visit database. Zero inter-rater variability — one clinician, one form, six years. The platform aggregates treatment pathways of cohort members who achieved significant improvement and presents this evidence-based cluster to the patient.
REAL-TIME • 100K+ VISITS • ZERO IRR
03
👨‍⚕️
On-Demand Walk-In Clinic
Not by appointment. Not tomorrow. Now. After the assessment, a licensed mental health provider is available immediately. The provider reviews the assessment, reviews AI pathway options, conducts a full clinical encounter, and deposits documentation into the patient’s permanent EMR. Direct admit initiated if needed.
IMMEDIATE • LIVE PROVIDER • DIRECT ADMIT READY
What Makes xaeonx.ai Unprecedented

Three capabilities.
One platform.
Never existed before.

Every other mental health platform solves one problem. xaeonx.ai solves three simultaneously — and the combination has never existed before in any healthcare platform.

Capability One
Patient-Owned
Distributed EMR

Developed inside xaeonx.ai. Free to every patient — no subscription, no fees, no charge to create, maintain, or use. Provided as a facility subscription for Colony DAO-connected admissions.

• Patient owns the record permanently — providers are guests
• Granular consent: patient approves each section, each provider
• Single unified record across every facility, every encounter
• HIPAA right of access structural — not administrative
• Hospitals relieved of EHR costs: $30K–$100K+/physician/year
No other EMR on earth works this way. Epic, Oracle, Athena — all institution-owned.
Capability Two
AI Psychiatric
Prediction System

Six years deployed. 100,000+ inpatient visits. Zero inter-rater variability — one clinician, one form, six years. Cohort matching on clinical presentation and symptom profile.

• Neurobiological, not demographic — same pharmacopeia globally
• 63% African American • 23% White • 17% Hispanic
• Perfect measurement invariance: same instruments 100K+ visits
• Adverse events database: 6-year catalog, risk stratification
• Biostatistician directing validity studies — publication Month 5
Zero inter-rater variability: the Achilles heel of every multi-site psychiatric AI — structurally eliminated.
Capability Three
Continuous Real-World
Evidence Platform

FDA Learning Health System model. Every patient interaction generates evidence that improves care for every future patient. The platform has been running the study for six years.

• Evidence generated continuously — at the point of care
• In the communities with the highest disease burden
• Not waiting for academic medical centers to study it
• FDA explicitly recognizes this model as high-quality SaMD evidence
• Biostatistician directing formal validity studies — submission Month 5
The platform has been running the study for 6 years. The biostatistician is writing it up.
Safety Architecture

Every session.
Every patient.
Question one: are you safe?

Before any assessment begins, every patient on xaeonx.ai answers a mandatory safety screening question. No exceptions. No shortcuts. Every interaction.

Mandatory First Question
“Are you currently having thoughts of suicide or harming yourself?”
Every patient • Every session • Timestamped • Documented
→ If YES
📞 Connect with 911 emergency services immediately
👨‍⚕️ Connect with live licensed crisis provider
No assessment proceeds until patient is connected with crisis support.
→ If NO
Patient proceeds to the full structured psychiatric and psychosocial assessment.
The platform also serves as a crisis line with direct ER referral capability. Live providers can initiate 911 directly from within the platform interaction.
The Patient-Owned Distributed EMR

The record belongs
to the patient.
Not the hospital.

Every other EMR in clinical deployment gives the institution ownership. xaeonx.ai gives it to the patient. Free. Permanent. Granular. The hospital accesses — it no longer owns.

Feature Epic / Oracle / Cerner xaeonx.ai
Safety Data & Evidence Generation

Six years of
documented safety.
Evidence already running.

The adverse events database covers the entire six-year operational period. The validity studies are actively collecting data. These are not future plans — they are current operations.

Adverse Events Database
6-Year
Catalog
Every adverse event over six years of platform operation is documented with a completed structured form, classification, and outcome. This is the most comprehensive real-world adverse event dataset in psychiatric AI. Enables risk stratification and behavior prediction — patients flagged based on cohort adverse event patterns.
FDA-READY SAFETY DATA • PROACTIVELY MAINTAINED
Validity Studies
Actively
Collecting
A biostatistician is directing formal validity studies using the 100,000+ visit operational database. Data collection is in progress for peer-reviewed publication documenting the relationship between cohort match quality, treatment concordance, and clinical outcomes. Manuscript submission target: Month 5.
BIOSTATISTICIAN ENGAGED • PUBLICATION TARGET: MONTH 5
Direct Admit
Operational &
Formalizing
Dr. Reed is on staff at a hospital and regularly admits patients through the direct admit route, bypassing the emergency department. This pathway has been operational for six years and is being formalized as a signed platform-level agreement — institutional, not personal.
OPERATIONAL 6 YEARS • PLATFORM AGREEMENT IN PROGRESS
Revenue Analysis

$2.28M to
$106M in five years.

Six revenue streams. Assessment fees, institutional licensing, payer contracts, pharmaceutical data, Genesis AI marketplace, and Colony DAO integration. Each stream compounds as the patient and provider network grows.

// revenue_streams_5yr
Revenue Streams Year 1–5 ($M)
All xaeonx.ai revenue streams stacked
6 streams • $2.28M Year 1 → $106M Year 5
// year5_revenue_mix
Year 5 Revenue Mix
Diversification at full operations
No single stream >35% • Diversified • Recurring • Compounding
// cumulative_10yr
10-Year Cumulative Revenue ($M)
vs $15M Series A investment
$15M Series A recovers by mid-Year 2 • $490M+ cumulative by Year 7
Year 5 Annual Revenue
$106,000,000
From a free psychiatric AI serving millions of patients in 12 care settings.
The assessment is always free. Revenue comes from institutions licensing the platform, payers saving on ER diversions, pharmaceutical research data, the Genesis AI marketplace, and Colony DAO data integration. Every care setting that joins the network adds another revenue channel — and another node in the referral network that serves every other institution on the platform.
White-Label xaeonx.ai

Your AI.
Your face.
Your patients.

Any registered healthcare provider or facility can deploy xaeonx.ai under their own brand. Upload your avatar or logo and xaeonx.ai presents itself as your AI — powered by Dr. Reed’s 26-year clinical database, wearing your face and your name.

How White-Labeling Works
01
Sign Up & Upload Avatar
Register as a Healthcare Provider or Facility. Upload your photo or logo. Your avatar appears on every patient-facing screen in your branded xaeonx.ai deployment.
02
Customize Your AI Identity
Choose your AI’s display name and specialty focus. Patients interact with “Dr. Smith’s AI” or “Roseland Mental Health AI.” The clinical engine is xaeonx.ai. The face is yours.
03
Deploy, Earn & Refer
Share your branded link. Receive assessments and consultation requests directly. Every patient interaction earns Colony DAO tokens. Every assessment can generate a referral through the xaeonx.ai network.
// payer_value_proposition
Payer Value Proposition
Annual savings per 100K enrolled members ($M)
Every payer has a financial incentive to contract with xaeonx.ai
// er_system_savings
System Savings from ER Bypass ($M)
Cumulative healthcare system savings Year 1–5
$2,264 saved per diverted ER patient • Millions of diversions by Year 5
xaeonx.ai Store

Wear the mission.
Support the work.

Every purchase supports Dr. Reed’s mission of free psychiatric care for every vulnerable child on earth. Clinical professionals, patients, advocates, and supporters — find something that speaks to where you stand.

xaeonx.ai Media

Learn. Watch.
Share. Comment.

Clinical education videos, Dr. Reed’s insights, patient stories, platform tutorials, investor briefings, and community discussions — all in one place. Watch, like, comment, and share with the xaeonx.ai community.

Welcome to xaeonx.ai Media
SELECT A VIDEO TO BEGIN
xaeonx.ai \u2014 Dr. Reed Introduction
xaeonx.ai Official 14,203 views April 2026
Dr. Jody Reed, MD introduces xaeonx.ai \u2014 the world’s first AI psychiatric prediction system, built on 26 years of single-rater clinical practice on Chicago’s South Side.
Comments 18 comments
YOU
XAEONX.AI CHANNEL
XA
xaeonx.ai Official
Dr. Jody Reed, MD • 6,214 subscribers
UP NEXT
ALL VIDEOS
Free Assessment • Provider Sign-Up

Patients: free.
Providers: live in hours.

Every patient completes their assessment for free — always. Healthcare providers, clinics, hospitals, schools, jails, prisons, and any institution can sign up today and deploy xaeonx.ai under their brand within hours. Full Referral Network access from day one.

Completely free for patients. No subscription, no payment info, no cost — ever.
12 care settings. Online, outpatient, inpatient, ER, schools, jails, prisons, community mental health, and more.
Referral Network from day one. Instantly connected to every provider in the network. Send and receive referrals in under 4 minutes.
Reach Dr. Reed directly. Patients can request a personal consultation at the end of any assessment.
// patients_helped_year1
Patients Helped Since Launch
Monthly assessments completed across all 12 care settings
Every number is a person • Every assessment is a step toward care
xaeonx_assessment.ai
★ WHITE-LABEL REGISTRATION — Deploy under your own name & avatar
+
Click to upload your photo
JPG, PNG • Max 5MB • Square crop recommended
★ FACILITY WHITE-LABEL REGISTRATION — Full institutional deployment
+
Click to upload your logo
JPG, PNG or SVG • Max 5MB
🔒 HIPAA COMPLIANT • SECURE • FREE ALWAYS
Confirmed.
Your xaeonx.ai registration is confirmed.
Dr. Reed’s AI is ready for you.

// Patients: prediction profile in minutes.
// Providers: deployment team in touch within 2 business days.
// Referral Network: access activated immediately.
📈  xaeonx.ai — Investor Business Plan · Series A $15M
xaeonx.ai • Investor Business Plan • April 2026 • Confidential

xaeonx.ai
Business Plan

The World's First AI Psychiatric Agent • Assess • Connect • Admit • xaeonx.ai

xaeonx.ai is not a chatbot. It is not a wellness app. It is a clinical-grade AI agent that conducts a complete, clinically-structured psychiatric evaluation through natural conversation — generating professional-grade documentation, predicting outcomes, creating evidence-based treatment recommendations, and connecting the patient to a licensed healthcare provider on demand. When inpatient care is needed, it coordinates a direct hospital admission, bypassing the ER entirely.

1. The Problem — 970 Million People, Not Enough Psychiatrists

MetricData
Global mental health market (2025)$491 billion
People living with mental illness970 million globally (1 in 8)
AI in mental health CAGR32% — growing to $25B by 2034
Average US wait time for a psychiatrist25 days — months in underserved communities
Average ER psychiatric boarding time11 hours for evaluation • 47 hours for a bed
Cost per ER psychiatric boarding patient$2,264 — over 8 million annual visits in the US
Global treatment gap50%+ of people needing care never receive it
xaeonx.ai initial evaluation cost to patient$0 — Free to every person on Earth

2. What xaeonx.ai Does

Complete Psychiatric Evaluation: Takes the patient's full history, administers validated screening instruments (PHQ-9, GAD-7, AUDIT, PCL-5, and others), conducts mental status examination, and generates a full written professional evaluation.
Evidence-Based Treatment Recommendations: Cross-references symptom profile, history, and risk factors against current clinical literature to generate personalized, evidence-grounded treatment recommendations for the receiving provider.
Outcome Prediction: Machine learning models trained on clinical outcomes data present predicted treatment response rates, risk stratification, and prognosis indicators for major evidence-based treatment modalities.
On-Demand Provider Connection: After evaluation, connects the patient via HIPAA-compliant videoconference to a licensed provider — with the complete evaluation already in the provider's hands.
Direct Inpatient Admission: For patients needing inpatient care, coordinates a direct admission to the behavioral health unit of the patient's chosen facility — bypassing the ER. Boarding time eliminated. Treatment begins hours sooner.
Ongoing Progress Notes & Discharge Summaries: Structured check-ins between appointments generate clinical progress notes. Discharge summaries ensure continuity of care across settings.

3. Revenue Architecture — Eight Streams

Revenue StreamMechanismYear 1Year 3Year 5
Hospital Direct Admissions$150–$300 per pre-evaluated direct admit$480K$4.2M$18M
Telehealth Provider Network$500–$2,000/mo per provider subscription$360K$3.6M$14M
Enterprise EHR Integration$50K–$500K/year per health system$500K$4.0M$16M
Payer & Insurance ContractsValue-based ER diversion contracts$250K$3.5M$22M
Employer EAP ProgramsEnterprise workforce wellness benefit$180K$2.1M$9M
Government & NGO ContractsPublic health programs, refugee mental health$300K$2.8M$12M
Premium Patient Services$9–$29/mo premium tier — expedited connection$120K$1.4M$8M
API LicensingDeveloper API for EHR and telemedicine platforms$90K$1.2M$7M
TOTAL$2.28M$22.8M$106M

4. Competitive Advantage — Four Defensible Moats

Clinical data network effect: Every conversation makes the AI more accurate. Every patient generates training signal that improves outcome predictions, crisis detection, and documentation quality. This advantage compounds continuously and cannot be replicated without the patient volume.
Hospital network effects: Every hospital joining the direct admission pathway increases the platform's value for all patients and providers. The more hospitals participate, the faster admissions can be arranged — and the harder it becomes for any competitor to match.
Multilingual first-mover advantage: Clinical-quality AI in all major global languages from launch is expensive and technically complex. Being first creates a substantial lead time that English-only or limited-language competitors cannot easily close.
Regulatory pathway as moat: Successfully navigating FDA De Novo authorization creates a regulatory clearance that competitors must match individually. xaeonx.ai becomes the predicate device for the AI psychiatric assessment category.

5. Competitive Landscape

CompetitorWhat They DoWhat They Cannot Do
Calm / HeadspaceMeditation, sleep, mood tracking, wellnessClinical assessment, professional documentation, crisis protocols, hospital admission coordination
Talkspace / BetterHelpConnect users with therapists for counselingPre-evaluation, psychiatric assessment, inpatient coordination, outcome prediction, free access
Woebot / WysaConversational mental health support, CBT exercisesClinical-grade evaluation, professional documentation, diagnosis support, direct admission pathway
Epic / CernerEHR-integrated clinical decision supportPatient-facing conversation, free access, multilingual global reach, standalone psychiatric evaluation

6. Use of $15M Series A

CategoryAllocationAmountKey Activities
Platform Development40%$6.0MClinical AI model fine-tuning, safety systems, crisis protocols, multilingual engine, EHR APIs, secure videoconference
FDA Regulatory Process15%$2.25MPre-submission meetings, De Novo application, clinical studies, regulatory counsel, QMS
Clinical Evidence Generation15%$2.25MProspective clinical studies at Colony Campus and partner sites, peer-reviewed publications
Hospital & Provider Network15%$2.25MHospital partnership agreements, provider network recruitment, integration support
International Market Entry10%$1.5M3 initial international markets, localization, regulatory compliance, partnership development
Operations & Team5%$0.75MCore leadership, legal, finance, compliance infrastructure
TOTAL100%$15M24 months to commercial US launch
xaeonx.ai Investor Business Plan • xaeonx.ai • Dr. Jody Reed, MD • 5de.ai • Roseland, Chicago • Confidential • Not a Securities Offering • April 2026
📄  xaeonx.ai White Paper — Single-Rater Longitudinal Prediction System for Psychiatric Care
White Paper • Pre-Publication Draft • April 2026 • Confidential

xaeonx.ai
White Paper

A Single-Rater Longitudinal Prediction System for Psychiatric Care • 26-Year Clinical Foundation • Zero Inter-Rater Variability

Abstract

xaeonx.ai is an artificial intelligence prediction system purpose-built for psychiatric care intake, longitudinal monitoring, and treatment pathway matching. Unlike conventional AI systems that aggregate data from thousands of clinicians across varied settings, xaeonx.ai is founded on a 26-year longitudinal clinical dataset authored entirely by a single clinician — eliminating inter-rater reliability problems that fundamentally compromise the accuracy of multi-source psychiatric databases. The system presents patients with statistically derived clinical pathway options based on cohort matching against historical patients who achieved significant symptom reduction at discharge. The patient selects their preferred pathway and is connected to their provider of choice.

1. The Reliability Crisis in Psychiatric AI

Psychiatry has been slower than radiology, pathology, or cardiology to realize the gains of AI. Not because psychiatric conditions are less amenable to computational analysis — they are not. But because the data on which psychiatric AI systems are trained carries a fundamental flaw that does not exist in the same form in other specialties: inter-rater variability.

The Core Insight: xaeonx.ai was founded on a different premise — that the most reliable psychiatric AI is not the one with the most data, but the one with the most internally consistent data. A 26-year longitudinal dataset created by a single clinician, using consistent methods and instruments throughout, eliminates the noise that makes other systems unreliable and replaces it with signal.

When AI systems are trained on data aggregated from thousands of different clinicians, inter-rater variability is not averaged out — it is amplified. The resulting system learns to predict from a noisy, internally inconsistent signal. It may achieve statistical performance on aggregate accuracy metrics while remaining unreliable at the level of the individual patient.

2. The Single-Rater Database — 26 Years, Zero Variability

The clinical database underlying xaeonx.ai was built over 26 years by a single clinician who personally authored every patient record, every clinical assessment, every symptom scale administration, every treatment note, every discharge summary, and every outcome document in the database. This is not a limitation. It is the most important methodological advantage that any psychiatric AI has ever possessed.

When one clinician creates all records in a dataset, the language used to describe the same symptom means the same thing in record number 1 as in record number 47,000. The threshold for calling a symptom 'clinically significant' on a rating scale is the same for Patient A in Year 2 as for Patient B in Year 24. A score of 22 on the Hamilton Depression Rating Scale in Year 1 reflects the same clinical severity as a score of 22 in Year 25 — because it was rated by the same person using the same standards.

3. The Prediction Engine — Seven Steps

StepFunction
1 — Patient IntakeStructured conversational assessment. AI guides patient through comprehensive clinical interview, administering validated psychiatric rating scales. Adapts in real time to disclosures.
2 — Documentation GenerationComplete initial psychiatric evaluation generated in professional clinical format — scale scores, narrative symptoms, clinical history, presenting concerns. Presented to patient for review.
3 — Cohort MatchingPatient's intake profile vector matched against the full 26-year single-rater database. Identifies all historical patients whose intake presentation was significantly similar. Creates the Matched Historical Cohort.
4 — Outcome StratificationMatched Cohort stratified by discharge outcome. Patients with clinically meaningful improvement on discharge scales separated from those who did not. Creates the Improved Outcome Subcohort.
5 — Pathway ExtractionWithin the Improved Outcome Subcohort, all treatment changes between intake and discharge aggregated and clustered into distinct pathway groups representing different routes to improvement.
6 — Pathway PresentationExtracted treatment pathways presented to patient in accessible language with associated outcome statistics. Patient reviews all options. Patient selects pathway for discussion with provider.
7 — Care CoordinationFacilitates connection to chosen care setting: on-demand video with provider, transmission to existing provider, or direct inpatient admission bypassing the ER.

4. xaeonx.ai vs. Conventional AI Systems

DimensionConventional AIxaeonx.ai
Data SourceMillions of records from thousands of clinicians26-year dataset from one clinician — maximum consistency
Inter-Rater ReliabilityFundamental structural problem — amplified by aggregationNot applicable — there is only one rater
Symptom LanguageHighly variable across clinicians and institutionsFully consistent — one vocabulary, one standard, 26 years
Cohort Matching ValidityMatch may be spurious — reflects rater differences, not clinical similarityMatch is real — same rater, same standards, same meaning
Prediction vs. DiagnosisMany systems attempt diagnostic labels — high regulatory riskExplicitly a prediction system — presents options, does not diagnose
Patient AgencyAI generates recommendations, moving toward clinical autonomyPatient selects pathway. Clinician advises. AI informs.
Regulatory PostureHigher FDA risk from diagnostic/prescriptive positioningDesigned for clinical intake facilitation — lower regulatory risk profile

5. Why xaeonx.ai Predicts Rather Than Diagnoses

The decision to build xaeonx.ai as a prediction system reflects both methodological honesty and a philosophical commitment to patient autonomy. Psychiatric diagnosis carries significant uncertainty — DSM-5 categories are descriptive, not etiological. What predicts treatment response more reliably is the specific clinical profile at a given moment: the exact constellation of symptoms, their severity, prior treatment responses, functional level, and social circumstances.

xaeonx.ai works at this level of specificity — bypassing the intermediate category of diagnosis and going directly to the question that matters: given this patient's complete current presentation, what treatment approaches have historically been associated with improvement in people who presented like them?

Patient Review and Approval: Before any evaluation or pathway information is transmitted to a healthcare provider, the patient reviews all documents generated by xaeonx.ai. The patient sees their complete psychiatric evaluation, their scale scores, the matched pathway options, and the outcome statistics. Nothing leaves the patient's hands without their knowledge and consent. This review step is not a formality — it is the mechanism by which xaeonx.ai returns clinical information to the person it describes.

6. The ER Bypass — Clinical and Systemic Significance

Patients in psychiatric crisis typically present to hospital emergency departments where they wait an average of 11 hours for a psychiatric evaluation and 47 hours for a behavioral health bed. When a patient arrives at a hospital with a complete, pre-existing xaeonx.ai evaluation — validated scale scores, full clinical history, and a care pathway selection — the psychiatric evaluation phase is already complete. The admitting team proceeds directly to treatment planning. Boarding time is eliminated. The patient begins receiving care hours or days sooner.

7. Privacy, Safety & Regulatory Framework

HIPAA-compliant architecture throughout — end-to-end encryption for all patient communications
Continuous real-time crisis detection — mandatory safety protocols activated on indicators of imminent risk, regardless of any other system function or patient selection
Zero patient data sold to third parties — patients retain access to and control over all documentation
FDA De Novo pathway being pursued for diagnostic functions — initial launch positioned as clinical intake facilitation tool
GDPR-compliant data architecture for international operations
HL7 FHIR-compliant API for integration with Epic, Cerner, and Athena EHR systems
xaeonx.ai White Paper • Pre-Publication Draft • xaeonx.ai • Dr. Jody Reed, MD • Colony Campus Development • Roseland, Chicago, Illinois • Not for Distribution Without Authorization • April 2026
📺  xaeonx.ai — Investor Presentation Slides · Series A $15M
Investor Presentation • Series A Materials • April 2026 • Confidential

xaeonx.ai
Investor Slides

Series A $15M • $106M Year 5 • 970M People • $0 Patient Cost • ER Bypass • xaeonx.ai

Summary of the xaeonx.ai investor presentation. For the full downloadable PowerPoint deck, contact Dr. Jody Reed at 5de.ai or xaeonx.ai.

SLIDE 01 — COVER
xaeonx.ai
The World's First AI Psychiatric Agent. Eliminating Access as a Barrier to Mental Healthcare — For Every Person on the Planet. Assess. Connect. Admit. xaeonx.ai
$106M Year 5
SLIDE 02 — THE CRISIS
970 Million People. No Access.
970 million people living with mental illness globally. Average 25-day wait for a psychiatrist in the US. Average 11-hour ER wait for psychiatric evaluation. 50%+ of people needing mental healthcare never receive it. Not because treatments don't exist. Because access is broken at the first step.
SLIDE 03 — THE ER CATASTROPHE
$2,264 Per Boarding Patient
Patients in psychiatric crisis wait an average of 47 hours in the ER for a behavioral health bed. This costs hospitals $2,264 per boarded patient. Over 8 million psychiatric ER visits annually in the US. xaeonx.ai directly attacks this problem through the direct admission pathway — ER bypassed entirely.
47-hour wait → 0
SLIDE 04 — THE SOLUTION
Clinical-Grade AI. $0 to Patient.
Complete psychiatric evaluation via AI conversation. Professional-grade clinical documentation generated automatically. Evidence-based treatment recommendations and outcome prediction. On-demand HIPAA-compliant video with licensed provider. Direct hospital admission — bypassing the ER. Available 24/7/365 in every language. Free for every patient.
SLIDE 05 — THE SCIENCE
26 Years. One Clinician. Zero Variability.
Every other psychiatric AI trains on aggregated data from thousands of clinicians — amplifying inter-rater variability into noise. xaeonx.ai trains on 26 years of records from one clinician. Zero inter-rater variability. Every matched historical patient is genuinely similar. Not a statistical artifact — a real clinical match.
SLIDE 06 — THE PREDICTION ENGINE
Predict. Inform. Connect. Choose.
Patient intake → documentation generation → cohort matching against 26-year database → outcome stratification → pathway extraction from improved subcohort → pathway presentation to patient → care coordination. xaeonx.ai does not diagnose. It shows patients what happened to people like them — and gives them the information to choose what comes next.
SLIDE 07 — MARKET
$491B Market. Every Human Being.
$491B global mental health market. $27.6B digital mental health growing to $58.7B by 2030. AI in mental health at 32% CAGR. But the true addressable market is every person who will ever need mental healthcare — because xaeonx.ai reaches the 50% who currently never seek care at all.
$491B TAM
SLIDE 08 — REVENUE
8 Streams. $2.28M → $106M.
Hospital direct admissions ($150–$300 each), telehealth provider subscriptions, enterprise EHR integration ($50K–$500K/yr), payer/insurance contracts, employer EAP programs, government/NGO contracts, premium patient services ($9–$29/mo), API licensing. $2.28M Year 1 → $22.8M Year 3 → $106M Year 5.
SLIDE 09 — GLOBAL REACH
Every Language. Every Country.
6.9 billion smartphone users globally. xaeonx.ai operates in all major global languages from launch. In Sub-Saharan Africa, fewer than 2 psychiatrists per million people. In South Asia, 150 million with mental illness — fewer than 10% have ever seen a professional. xaeonx.ai eliminates the limiting factor in every language, in every country.
SLIDE 10 — COMPETITIVE MOATS
Four Defensible Advantages
Clinical data network effect (every conversation improves accuracy). Hospital network effects (every partner hospital increases direct admission value). Multilingual first-mover (expensive and complex to replicate). FDA De Novo regulatory moat (xaeonx.ai becomes the predicate device for the AI psychiatric assessment category).
SLIDE 11 — ECOSYSTEM
Platform Two of the 5D Earth Ecosystem
Colony Campus (Part 1) provides the real hospital environment for clinical validation and evidence generation. xaeonx.ai (Part 2) is the first product built on the Genesis platform — the proof of concept. Genesis (Part 3) makes xaeonx.ai replicable for every specialty. Together: $805M+ Year 5 ecosystem revenue.
SLIDE 12 — ROSELAND CONTEXT
Proof of Concept for the World
Colony Campus in Roseland, Chicago — 7% of Chicago's population, 16% of its COVID-19 deaths, life expectancy 10 years below the North Side, psychiatric care essentially inaccessible. xaeonx.ai was built to solve this specific problem — and the Roseland solution applies to every underserved community in America and every low-resource health system on Earth.
SLIDE 13 — ROADMAP
Q3 2026 → Commercial US Launch
Q3 2026: Series A closes ($15M). Platform development begins. FDA regulatory process initiated. Q4 2026: Colony Campus validation site activated. Clinical evidence collection begins. Q1 2027: First 10 hospital partnerships. Provider network recruitment. Q3 2027: Commercial US launch. Q4 2027: First 3 international markets. Year 5: $106M revenue.
SLIDE 14 — THE INVESTMENT CASE
The Most Important Mental Healthcare Investment of the Decade.
The global mental health treatment gap is not a drug problem, a therapy problem, or a funding problem. It is an access problem. Before any treatment can begin, a patient must be assessed. And assessment requires a trained professional who is unavailable to most of the world. xaeonx.ai is the first technology that can close that gap at scale — clinical-grade, multilingual, free to every patient, available 24/7, with a direct hospital admission pathway that saves hospitals $2,264 per diverted ER patient. $15M Series A. $106M Year 5. $490M+ 10-year cumulative. For the full deck, contact invest@xaeonx.ai or Dr. Jody Reed at 5de.ai.
$15M → $106M Year 5
To request the full xaeonx.ai PowerPoint investor deck, the complete White Paper, or a meeting with Dr. Jody Reed, MD — contact xaeonx.ai or 5de.ai.
xaeonx.ai Investor Presentation • xaeonx.ai • Dr. Jody Reed, MD • 5de.ai • Roseland, Chicago, Illinois • Confidential • Not a Securities Offering • Consult Qualified Advisors Before Any Investment Decision • April 2026